Mike Kenny, Teresa Bonder, Matthew Kent, and Andrew Hatchett are mentioned for representing Sandoz Inc. in antitrust litigation.
In the News
May 16, 2019
Law360 | Blood Clot Drug Buyers Must Redo Class Cert. Bid
Related News & Insights
-
In the News April 18, 2018Law360 | Momenta, Sandoz Ask to Appeal Antitrust Claims Mid-SuitTeresa Bonder, Matthew Kent, Michael Kenny, and Andrew Hatchett are noted for representing Sandoz Inc. in an antitrust suit.
-
In the News March 20, 2018Law360 | Momenta, Sandoz Can’t Dodge Amphastar Antitrust SuitMatthew Kent, Mike Kenny, Teresa Bonder, and Andrew Hatchett are noted for representing Sandoz in an antitrust lawsuit.
-
In the News April 26, 2017Law360 | Allergan Settles Apotex Pinkeye Meds Product-Hopping SuitMike Kenny, Teresa Bonder, Matthew Kent, Andrew Hatchett, Matt Lawson, and Allison Thompson are mentioned for representing Appotex, Inc., in an antitrust lawsuit.
-
In the News April 20, 2017Law360 | Momenta, Sandoz Again Try To Nix Amphastar's Antitrust SuitMike Kenny, Teresa Bonder, Matthew Kent, Andrew Hatchett, and Kimberly Chemerinsky are mentioned for representing Sandoz, Inc.
-
In the News April 6, 2017Law360 | Amphastar, Momenta Antitrust Dispute Gets 2019 Trial DateMatthew Kent, Teresa Bonder, Mike Kenny, Kimberly Chemerinsky, and Andrew Hatchett are noted for representing Sandoz, Inc.
Media Contact